tiprankstipranks
Trending News
More News >
Verrica Pharmaceuticals (VRCA)
:VRCA
US Market

Verrica Pharmaceuticals (VRCA) Income Statement

Compare
480 Followers

Verrica Pharmaceuticals Income Statement

Last quarter (Q3 2025), Verrica Pharmaceuticals's total revenue was $14.34M, a decrease of -905.39% from the same quarter last year. In Q3, Verrica Pharmaceuticals's net income was $-274.00K. See Verrica Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.57M$ 5.12M$ 9.03M$ 12.00M$ 0.00
Gross Profit
$ 4.83M$ 4.38M$ 8.31M$ 11.53M$ -229.00K
Operating Expenses
$ 70.75M$ 70.14M$ 29.60M$ 42.44M$ 39.95M
Depreciation and Amortization
$ 1.27M$ 836.00K$ 718.00K$ 472.00K$ 229.00K
EBITDA
$ -65.90M$ -62.20M$ -21.60M$ -30.31M$ -39.43M
Operating Income
$ -65.92M$ -65.76M$ -21.30M$ -30.91M$ -40.18M
Other Income/Expenses
$ -10.66M$ -1.24M$ -3.19M$ -4.17M$ -2.51M
Pretax Income
$ -76.58M$ -67.00M$ -24.49M$ -35.08M$ -42.69M
Net Income
$ -76.58M$ -67.00M$ -24.49M$ -35.08M$ -45.50M
Per Share Metrics
Basic EPS
$ -14.78$ -14.78$ -7.17$ -12.97$ -17.08
Diluted EPS
$ -14.78$ -14.78$ -7.17$ -12.97$ -17.08
Weighted Average Shares Outstanding
5.18M 4.53M 3.42M 2.70M 2.50M
Weighted Average Shares Outstanding (Diluted)
5.18M 4.53M 3.42M 2.70M 2.50M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History